Filter
763
Text search:
antibody
tests
Featured
116
190
Language
Document type
329
207
92
58
37
13
12
5
4
3
1
1
Countries / Regions
69
41
27
19
14
13
12
12
11
11
11
10
9
9
9
8
8
8
8
7
7
7
7
6
6
5
5
5
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
275
129
40
34
22
15
14
Toolboxes
140
93
68
27
19
19
19
15
14
14
14
12
11
8
8
8
6
5
2
2
1
1
Accessed Febr. 6, 2020
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera
...
Научная справка
24 апреля 2020 г.
При инфицировании в естественных условиях выработка иммунитета к патогенному микроорганизму проходит в несколько этапов и заним
...
Available in English, French, Spanish, Chinese, Russian and Arabic
https://apps.who.int/iris/handle/10665/337832
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr
...
12 February 2021
Orientations provisoires
9 août 2021
Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractér
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2,
...
Testing Guidance and Interpretation of Results for Healthcare Providers
Zika Virus Testing Guidance: Asymptomatic Pregnant Women
with Possible Zika Virus Exposure
This guidance synthesizes current evidence on dengue laboratory testing and diagnostics and provides practical recommendations for laboratories, clinicians, public health officials, and programme managers involved in dengue diagnosis, surveillance, and control, in the context of the global emergency
...
Six maladies évitables par la vaccination ont été incluses dès le
début dans le PEV : la diphtérie, la rougeole, la coqueluche, la
poliomyélite, le tétanos et la tuberculose.
J. European Academy of Dermatology and Venereology, 4 August 2014
Accessed: 29.09.2019
